Our  plans focus on finding solutions to the problems of the World Health Organization's priorities.

Priority Diseases

The World Health Organization (WHO) has identified a list of priority diseases that pose significant public health risks due to their epidemic potential and lack of effective countermeasures.
The current priority disease include:

Covid-19.
Crimean-Congo haemorrhagic fever ( CCHF ).
Ebola virus disease and Marburg virus disease.
Lassa fever.
Middle East respiratory syndrome coronavirus ( MERS-CoV ).
Severe Acute Respiratory Syndrome ( SARS ).
Nipah and henipaviral diseases.
Rift Valley fever ( RVF ).
Zika Disease .

Disease X . ( a placeholder for a hypothetical ,unknown pathogen that could cause a serious international epidemic ).

Collaboration 

We are ready  to cooperate with educational, academic, research centers and specialized scientific companies.

We are honored by the joint cooperation and protocol with

المركز القومي للبحوث 

وحده تطوير  اللقاحات والأختبارات الفيروسية

CSEIV

aAI -driven drug discovery

" Drugs getting to the right patient at the right time "
AI  can help people live longer, healthier lives ....
Many diseases today don’t have a cure. One reason is that drug discovery is difficult: finding and developing an effective medicine is a years long and very expensive process. But maybe it doesn’t have to be. AI—if properly integrated into scientists’ research—could revolutionize drug discovery, making it possible for more patients to get the treatments they need. and we are here through our innovation  sector and our partners network .

Researches & Publications
We pursuit of solutions for non-curable diseases and resistant pathogens.
The departure point for selection the appropriate drug for certain disease starts from “ Multi target-directed ligands/polypharmacolgy ".
Discovery the most effective, compatible and safe solutions delicate our  vision.

Body Systems Integration Solutions.
Social Immunity Instrument.
Innovations of new molecules for curing the pandemic/endemic diseases.
Artificial Intelligence (aAI) applications in drug development and health care.
Cognitive Behavioral Therapy (CBT).
Climate Change.
SARS-Cov-2 Covid-19.
Long Covid-19 Syndrome.
Post vaccinated 
Cytokines & Inflammatory Disease.
Natural products & drug discovery.
Pediatric.

 aAI & Innovation  @ Rock Enterprise

2024

Address


CAIRO, EG

About us

The Heart of Misr Investment ' Pharmaceutical manufacturing, Health Care and Scientific Research (Ibn Misr Science)®. 
All rights reserved 2024.

Last Update: Jan 20, 2025.

Follow us